Cargando…
Correction to: Innovative radiation oncology Together—Precise, Personalized, Human
Autores principales: | Krug, David, Hecht, Markus, Ebert, Nadja, Mäurer, Matthias, Fleischmann, Daniel F., Fokas, Emmanouil, Straube, Christoph, Nicolay, Nils Henrik, Hörner-Rieber, Juliane, Schmitt, Daniela, von Neubeck, Cläre, Zamboglou, Constantinos, Sperk, Elena, Kaul, David, Hess, Julia, Corradini, Stefanie, Seidel, Clemens, Gani, Cihan, Baues, Christian, Frey, Benjamin, Blanck, Oliver, Gauer, Tobias, Niyazi, Maximilian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604837/ https://www.ncbi.nlm.nih.gov/pubmed/34731288 http://dx.doi.org/10.1007/s00066-021-01869-z |
Ejemplares similares
-
Innovative radiation oncology Together – Precise, Personalized, Human: Vision 2030 for radiotherapy & radiation oncology in Germany
por: Krug, David, et al.
Publicado: (2021) -
Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group
por: Käsmann, Lukas, et al.
Publicado: (2020) -
Complete response after chemoradiotherapy for rectal cancer: what is the reasonable approach?
por: Rödel, Claus, et al.
Publicado: (2017) -
C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy
por: Frey, Alina, et al.
Publicado: (2022) -
Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer—results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group
por: Ostheimer, C., et al.
Publicado: (2021)